In the last trading session, 1.19 million Applied Therapeutics Inc (NASDAQ:APLT) shares changed hands as the company’s beta touched 1.87. With the company’s per share price at $0.37 changed hands at $0.01 or 1.48% during last session, the market valuation stood at $52.27M. APLT’s last price was a discount, traded about -2770.27% off its 52-week high of $10.62. The share price had its 52-week low at $0.29, which suggests the last value was 21.62% up since then.
Analysts gave the Applied Therapeutics Inc (APLT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.25. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended APLT as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Applied Therapeutics Inc’s EPS for the current quarter is expected to be -0.17.
Applied Therapeutics Inc (NASDAQ:APLT) trade information
Instantly APLT was in green as seen at the end of in last trading. With action 4.50%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -56.88%, with the 5-day performance at 4.50% in the green. However, in the 30-day time frame, Applied Therapeutics Inc (NASDAQ:APLT) is -12.10% down.
The consensus price target for the stock as assigned by Wall Street analysts is 4.5, meaning bulls need an upside of 91.78% from its current market value. According to analyst projections, APLT’s forecast low is 4 with 5 as the target high. To hit the forecast high, the stock’s price needs a -1251.35% plunge from its current level, while the stock would need to soar -981.08% for it to hit the projected low.
Applied Therapeutics Inc (APLT) estimates and forecasts
Year-over-year growth is forecast to reach 174.73% up from the last financial year.
Consensus estimates given by 3 financial analysts project the company’s revenue in the current quarter to hit an average of 416.67k. 3 analysts are of the opinion that Applied Therapeutics Inc’s revenue for the current quarter will be 416.67k. The company’s revenue for the corresponding quarters a year ago was 144k and 122k respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 189.35%. The estimates for the next quarter sales put growth at 241.53%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 26.57%. The 2025 estimates are for Applied Therapeutics Inc earnings to increase by 23.30%, but the outlook for the next 5-year period is at 24.56% per year.
APLT Dividends
Applied Therapeutics Inc is expected to release its next quarterly earnings report in July.
VR ADVISER, LLC holds the second largest percentage of outstanding shares, with 66.1112% or 9.54 million shares worth $44.57 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were T. Rowe Price Small-Cap Value Fund, Inc. and Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF . With 6.47 shares estimated at $2.39 million under it, the former controlled 4.57% of total outstanding shares. On the other hand, Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF held about 3.17% of the shares, roughly 4.49 shares worth around $1.66 million.
